Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CH3(CH2)14CO2(CH2)15CH3
CAS Number:
Molecular Weight:
480.85
UNSPSC Code:
12352211
PubChem Substance ID:
EC Number:
208-736-6
MDL number:
assay
98%
mp
55-56 °C (lit.)
SMILES string
CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC
InChI
1S/C32H64O2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-34-32(33)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-31H2,1-2H3
InChI key
PXDJXZJSCPSGGI-UHFFFAOYSA-N
Storage Class
11 - Combustible Solids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
G Lukowski et al.
International journal of pharmaceutics, 196(2), 201-205 (2000-03-04)
Solid lipid nanoparticles (SLN) as alternative intravenous colloidal drug carriers were produced by high pressure homogenisation of the melted lipid cetylpalmitate. The crystallographic properties of the used cetylpalmitate SLN were characterised by small angle X-ray scattering (SAXS) and X-ray diffraction
Paolo Blasi et al.
International journal of pharmaceutics, 419(1-2), 287-295 (2011-08-11)
The aim of this study was to optimize the formulation of lipid nanoparticles (NPs), intended for brain targeting, with the aid of a computer generated experimental design. The high pressure homogenization technique, selected for this purpose, was suitable to formulate
C Carbone et al.
European journal of medicinal chemistry, 49, 110-117 (2012-01-17)
The objective of this study was the preparation, physico-chemical characterization and statistical optimization of cationic solid lipid nanoparticles (SLN) prepared by the PIT method as potential carrier for gene therapy, emphasizing the application of factorial design in such a kind